Diversified Healthcare Trust (DHC)
Market Price (2/3/2026): $5.845 | Market Cap: $1.4 BilSector: Real Estate | Industry: Health Care REITs
Diversified Healthcare Trust (DHC)
Market Price (2/3/2026): $5.845Market Cap: $1.4 BilSector: Real EstateIndustry: Health Care REITs
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Precision Medicine. Themes include Geriatric Care, and Biopharmaceutical R&D. | Trading close to highsDist 52W High is -2.8%, Dist 3Y High is -2.8% | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -39 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -2.5% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 180% | ||
| Expensive valuation multiplesP/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 75x | ||
| Stock price has recently run up significantly12M Rtn12 month market price return is 138% | ||
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -29% | ||
| Key risksDHC key risks include [1] substantial leverage and challenging debt maturities that have raised going concern doubts, Show more. |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, and Precision Medicine. Themes include Geriatric Care, and Biopharmaceutical R&D. |
| Trading close to highsDist 52W High is -2.8%, Dist 3Y High is -2.8% |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -39 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -2.5% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 180% |
| Expensive valuation multiplesP/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 75x |
| Stock price has recently run up significantly12M Rtn12 month market price return is 138% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -29% |
| Key risksDHC key risks include [1] substantial leverage and challenging debt maturities that have raised going concern doubts, Show more. |
Qualitative Assessment
AI Analysis | Feedback
1. Analyst Upgrades and Increased Price Targets.
In November 2025, RBC Capital upgraded Diversified Healthcare Trust's rating from "underperform" to "sector perform," simultaneously raising its price target from $3.00 to $5.00. This upgrade reflected RBC Capital's view that DHC's senior housing operating portfolio (SHOP) was well-positioned to benefit from favorable industry trends and improved leverage. This positive sentiment was further bolstered in December 2025 when B. Riley reiterated a "buy" rating and increased its price objective for DHC from $5.50 to $6.50.
2. Strategic Capital Recycling and Significant Debt Reduction.
Diversified Healthcare Trust successfully executed its capital recycling program throughout 2025, completing the sale of 69 non-core properties for approximately $605 million, including $250 million generated in the fourth quarter of 2025 alone. A crucial development was the full repayment of its zero coupon senior secured notes due in 2026 on December 29, 2025, utilizing cash on hand and proceeds from these asset sales. This eliminated a significant near-term debt maturity and released 45 collateral properties, enhancing the company's financial flexibility as it now has no debt maturing until 2028.
Show more
Stock Movement Drivers
Fundamental Drivers
The 37.3% change in DHC stock from 10/31/2025 to 2/2/2026 was primarily driven by a 36.1% change in the company's P/S Multiple.| (LTM values as of) | 10312025 | 2022026 | Change |
|---|---|---|---|
| Stock Price ($) | 4.25 | 5.84 | 37.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,523 | 1,538 | 1.0% |
| P/S Multiple | 0.7 | 0.9 | 36.1% |
| Shares Outstanding (Mil) | 240 | 240 | -0.1% |
| Cumulative Contribution | 37.3% |
Market Drivers
10/31/2025 to 2/2/2026| Return | Correlation | |
|---|---|---|
| DHC | 37.3% | |
| Market (SPY) | 2.0% | 2.1% |
| Sector (XLRE) | 0.1% | 19.2% |
Fundamental Drivers
The 79.3% change in DHC stock from 7/31/2025 to 2/2/2026 was primarily driven by a 76.6% change in the company's P/S Multiple.| (LTM values as of) | 7312025 | 2022026 | Change |
|---|---|---|---|
| Stock Price ($) | 3.26 | 5.84 | 79.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,512 | 1,538 | 1.7% |
| P/S Multiple | 0.5 | 0.9 | 76.6% |
| Shares Outstanding (Mil) | 240 | 240 | -0.2% |
| Cumulative Contribution | 79.3% |
Market Drivers
7/31/2025 to 2/2/2026| Return | Correlation | |
|---|---|---|
| DHC | 79.3% | |
| Market (SPY) | 10.3% | 16.3% |
| Sector (XLRE) | -0.3% | 33.3% |
Fundamental Drivers
The 138.2% change in DHC stock from 1/31/2025 to 2/2/2026 was primarily driven by a 129.5% change in the company's P/S Multiple.| (LTM values as of) | 1312025 | 2022026 | Change |
|---|---|---|---|
| Stock Price ($) | 2.45 | 5.84 | 138.2% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,477 | 1,538 | 4.1% |
| P/S Multiple | 0.4 | 0.9 | 129.5% |
| Shares Outstanding (Mil) | 240 | 240 | -0.3% |
| Cumulative Contribution | 138.2% |
Market Drivers
1/31/2025 to 2/2/2026| Return | Correlation | |
|---|---|---|
| DHC | 138.2% | |
| Market (SPY) | 16.6% | 28.9% |
| Sector (XLRE) | 1.2% | 33.3% |
Fundamental Drivers
The 675.3% change in DHC stock from 1/31/2023 to 2/2/2026 was primarily driven by a 552.5% change in the company's P/S Multiple.| (LTM values as of) | 1312023 | 2022026 | Change |
|---|---|---|---|
| Stock Price ($) | 0.75 | 5.84 | 675.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 1,283 | 1,538 | 19.8% |
| P/S Multiple | 0.1 | 0.9 | 552.5% |
| Shares Outstanding (Mil) | 238 | 240 | -0.8% |
| Cumulative Contribution | 675.3% |
Market Drivers
1/31/2023 to 2/2/2026| Return | Correlation | |
|---|---|---|
| DHC | 675.3% | |
| Market (SPY) | 77.5% | 23.0% |
| Sector (XLRE) | 10.7% | 34.9% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| DHC Return | -24% | -79% | 498% | -38% | 114% | 20% | 55% |
| Peers Return | 10% | -11% | 17% | 27% | 27% | 1% | 86% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 1% | 85% |
Monthly Win Rates [3] | |||||||
| DHC Win Rate | 42% | 25% | 75% | 50% | 67% | 50% | |
| Peers Win Rate | 53% | 43% | 62% | 70% | 60% | 30% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| DHC Max Drawdown | -40% | -79% | 0% | -41% | -11% | 0% | |
| Peers Max Drawdown | -12% | -22% | -9% | -11% | -5% | -2% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: WELL, VTR, OHI, NHI, HR.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 2/2/2026 (YTD)
How Low Can It Go
| Event | DHC | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -88.4% | -25.4% |
| % Gain to Breakeven | 758.7% | 34.1% |
| Time to Breakeven | 1,113 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -75.9% | -33.9% |
| % Gain to Breakeven | 314.6% | 51.3% |
| Time to Breakeven | Not Fully Recovered days | 148 days |
| 2018 Correction | ||
| % Loss | -68.3% | -19.8% |
| % Gain to Breakeven | 215.4% | 24.7% |
| Time to Breakeven | Not Fully Recovered days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -58.7% | -56.8% |
| % Gain to Breakeven | 141.9% | 131.3% |
| Time to Breakeven | 703 days | 1,480 days |
Compare to WELL, VTR, OHI, NHI, HR
In The Past
Diversified Healthcare Trust's stock fell -88.4% during the 2022 Inflation Shock from a high on 3/15/2021. A -88.4% loss requires a 758.7% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Diversified Healthcare Trust (DHC)
AI Analysis | Feedback
```html- Prologis for healthcare properties.
- Simon Property Group for medical facilities and senior living communities.
AI Analysis | Feedback
- Senior Living Communities: DHC owns and leases properties providing independent living, assisted living, and memory care services to seniors.
- Medical Office Buildings: DHC offers specialized office spaces for lease to various healthcare providers, including doctors' offices, clinics, and outpatient facilities.
- Life Science Properties: DHC provides laboratory, research, and development facilities for lease to biotechnology and pharmaceutical companies.
AI Analysis | Feedback
Major Customers of Diversified Healthcare Trust (DHC)
Diversified Healthcare Trust (DHC) is a real estate investment trust (REIT) that owns and leases healthcare-related properties, including medical office buildings, skilled nursing facilities, senior living communities, and wellness centers. Its major customers are other companies that operate healthcare facilities or practices in the properties owned by DHC.
The primary customer company is:
- Five Star Senior Living (FVE): Five Star Senior Living is a significant operator and tenant for a large portion of DHC's senior living communities. DHC leases many of its senior living properties to FVE, which then manages and operates those communities.
Beyond Five Star Senior Living, DHC's other properties (such as medical office buildings, skilled nursing facilities, and wellness centers) are leased to a diverse group of other healthcare operators, medical practices, hospital systems, and wellness providers. These tenants are typically varied, and no single other entity generally constitutes a "major customer" representing a substantial portion of DHC's overall revenue.
AI Analysis | Feedback
- The RMR Group Inc. (RMR)
- AlerisLife Inc. (ALR)
AI Analysis | Feedback
Chris Bilotto, President and Chief Executive Officer
Mr. Bilotto has served as President and Chief Executive Officer of Diversified Healthcare Trust (DHC) since 2024. He is also an Executive Vice President of The RMR Group (RMR), the company that manages DHC, and a member of the RMR Management Committee. Additionally, he holds the positions of Managing Trustee, President, and Chief Executive Officer of Service Properties Trust (SVC). At RMR, Mr. Bilotto is responsible for acquisitions, asset management for all hotel and senior living properties, and development and redevelopment activities across the U.S. Before joining RMR in 2011, he held various management roles at General Growth Properties (NYSE: GGP), focusing on shopping malls and mixed-use assets. He possesses 20 years of experience in the commercial real estate industry, specializing in asset management, leasing, and development.
Matthew Brown, Chief Financial Officer and Treasurer
Mr. Brown has been the Chief Financial Officer and Treasurer of Diversified Healthcare Trust (DHC) since 2023. He also serves as an Executive Vice President, Chief Financial Officer, and Treasurer of The RMR Group (RMR), where he oversees accounting, finance, and tax functions. His roles also include Chief Financial Officer and Treasurer of Tremont Realty Capital and Seven Hills Realty Trust (SEVN). Previously, Mr. Brown was the Chief Financial Officer and Treasurer of Office Properties Income Trust (OPI), another RMR company, and served as Director of Financial Reporting for DHC. Before joining RMR in 2007, he worked in the audit practice of Wolf & Company, a public accounting firm. He is a certified public accountant.
Adam Portnoy, Chair of the Board of Trustees
Mr. Portnoy serves as the Chair of DHC's Board of Trustees. He is also the President and Chief Executive Officer of The RMR Group (RMR), an alternative asset management company founded in 1986 that invests in commercial real estate and related operating businesses, with $32 billion in assets under management. Mr. Portnoy joined RMR in 2003. Prior to his time at RMR, he held various positions in the finance industry and public sector. His experience includes working as a banker at Donaldson, Lufkin & Jenrette and ABN AMRO, and in private equity at the International Finance Corporation (part of The World Bank Group) and DLJ Merchant Banking Partners. He also served as Chief Executive Officer of a telecommunications company. Mr. Portnoy serves on the Boards of several other companies managed by RMR or its affiliates, demonstrating a pattern of involvement with companies managed by The RMR Group, which itself is an alternative asset management company.
Jennifer B. Clark, Secretary
Ms. Clark is the Secretary of Diversified Healthcare Trust. She is also listed as a Co-Managing Trustee at Office Properties Income Trust, a company managed by The RMR Group.
Anthony Paula, Vice President
Mr. Paula serves as a Vice President of Diversified Healthcare Trust.
AI Analysis | Feedback
The key risks to Diversified Healthcare Trust (DHC) primarily revolve around its financial structure and the performance of its core assets:
- High Leverage and Debt Maturities: Diversified Healthcare Trust carries a substantial debt load, reported at nearly $2.9 billion, which significantly limits its financial flexibility and ability to reinvest or grow the portfolio. The company faces ongoing challenges in refinancing its debt, especially with secured notes maturing in 2026. Rising interest rates could further increase borrowing costs, impacting margins and potentially necessitating asset sales to meet obligations. This high leverage has previously led to a default on a credit facility due to a drop in collateral value and raised "substantial doubt" about DHC's ability to continue as a going concern.
- Concentration Risk and Performance of Senior Housing Operating Portfolio (SHOP): DHC has a significant concentration in its Senior Housing Operating Portfolio (SHOP) segment, with 118 communities managed by Five Star Senior Living. The underperformance of this segment or its operator would disproportionately affect DHC's overall financial results. Despite some recent improvements in occupancy and net operating income, analysts have expressed concerns about maintaining this performance, particularly if the company must reduce capital expenditures for property upgrades and renovations due to financial constraints.
- Rising Operating Expenses and Regulatory Changes: The healthcare real estate sector, including DHC's senior living portfolio, is highly sensitive to rising operating expenses, particularly labor costs. These increasing costs directly impact profitability and put pressure on profit margins. Additionally, the sector is exposed to regulatory changes, such as shifts in Medicare or Medicaid reimbursement rates, labor laws, or compliance practices, which can negatively affect operator performance and operating margins.
AI Analysis | Feedback
- The ongoing shift towards the decentralization of healthcare delivery, with an increasing prevalence of outpatient facilities, urgent care centers, and retail health clinics. This trend could diminish the demand for traditional, larger medical office buildings that constitute a significant portion of DHC's portfolio, as care moves closer to where people live and shop, potentially impacting occupancy rates and rent growth.
- The sustained and growing adoption of telehealth services post-pandemic. If a significant portion of routine medical consultations permanently shifts to virtual platforms, it could reduce the overall physical space required by healthcare providers for exam rooms and waiting areas, thereby decreasing future demand for traditional medical office space and potentially impacting DHC's leasing activity and rental income.
- Chronic and worsening labor shortages across the senior living and healthcare sectors. These shortages directly impact the operational viability and profitability of DHC's senior living operators (tenants), limiting their ability to admit residents, maintain occupancy, and generate sufficient revenue. This, in turn, poses a direct threat to DHC's ability to collect rent and maintain stable income from its senior living portfolio.
AI Analysis | Feedback
Diversified Healthcare Trust (DHC) operates as a real estate investment trust (REIT) primarily focused on owning and leasing healthcare properties across the United States. Their main products and services include senior living communities, medical office buildings, and life science properties.
Addressable Markets for Diversified Healthcare Trust's Main Products or Services (U.S. Region):
- Senior Living Communities: The addressable market for senior living in the U.S. was estimated at approximately $907.59 billion in 2024 and is projected to reach $943.90 billion in 2025. This market is expected to grow to around $1.39 trillion by 2033.
- Medical Office Buildings (MOBs): The U.S. medical office buildings market generated approximately $14.08 billion in revenue in 2023. It is projected to reach about $22.04 billion by 2030.
- Life Science Properties: null
AI Analysis | Feedback
Diversified Healthcare Trust (DHC) is expected to drive future revenue growth over the next 2-3 years through several key strategies and market trends:
-
Senior Housing Operating Portfolio (SHOP) Occupancy and Rate Improvements: DHC has demonstrated consistent growth in its Senior Housing Operating Portfolio, with occupancy rising by 210 basis points year-over-year to 81.5%, marking four consecutive quarters of occupancy growth. The company anticipates further gains as occupancy trends continue to improve and average monthly rates increase, with year-over-year same-property SHOP revenue growing by 6.6%. This sustained recovery in senior housing demand is a core belief for DHC shareholders.
-
Medical Office and Life Science Leasing Success: DHC has shown strong performance in its medical office and life science segments, completing approximately 86,000 square feet of leasing at weighted average rents 9% above prior rents, with an average lease term of nearly seven years. This success, coupled with an increase in consolidated occupancy in this portfolio by 370 basis points sequentially to 86.6% (driven by strategic asset sales and new leasing), underscores the company's strong position in these high-growth sectors.
-
Portfolio Optimization and Strategic Asset Sales: The company is actively optimizing its portfolio through asset dispositions. DHC has sold 44 properties for $396 million year-to-date and has agreements to sell an additional 38 properties for $237 million. These sales are aimed at enhancing liquidity, reducing capital expenditures, improving overall occupancy and margins, and contributing to cash flow growth. The full transition of 116 AlerisLife-managed communities to new operators, expected to be completed by year-end, is also anticipated to yield $25 million to $40 million in net proceeds in 2026 and contribute to margin expansion through performance-based incentive structures.
-
Leveraging Aging Demographics and Healthcare Tailwinds: An overarching driver for DHC is the favorable demographic trend of an aging population, combined with advancements in medical technologies. DHC has made significant portfolio-wide investments in its medical office, life science, and senior housing assets, positioning the company to capitalize on these powerful tailwinds and serve increasing demand in the healthcare real estate sector.
AI Analysis | Feedback
Share Repurchases
No specific dollar amount of share repurchases made or authorized to be made by Diversified Healthcare Trust (DHC) over the last 3-5 years was found in the provided information.
Share Issuance
No specific dollar amount of shares issued by Diversified Healthcare Trust (DHC) for capital raising purposes over the last 3-5 years was found in the provided information. Information regarding "DHC Acquisition" and its IPO or business combination refers to a different entity (a SPAC) and not Diversified Healthcare Trust.
Inbound Investments
No significant inbound investments by third-parties (e.g., strategic partners or private equity firms) directly into Diversified Healthcare Trust (DHC) were found in the provided information.
Outbound Investments
- Diversified Healthcare Trust has been engaged in the sale of non-core assets to reduce capital spending, improve occupancy and margins, and enhance cash flow. As of November 3, 2025, DHC had sold 44 properties for $396 million year-to-date.
- The company has agreements or letters of intent to sell an additional 38 properties for $237 million, with $211 million expected to close in Q4 2025 and the remainder in Q1 2026.
- DHC also plans to use expected proceeds of approximately $301 million from asset sales in Q1 2025 to pay down its 2026 zero coupon secured notes.
Capital Expenditures
- Diversified Healthcare Trust's annual capital expenditures were $374.492 million in 2022, $235.007 million in 2023, and $201.702 million in 2024.
- The company reaffirmed its 2025 capital expenditure guidance at $140-$160 million.
- The primary focus of capital expenditures includes refreshes and redevelopments aimed at achieving incremental Net Operating Income (NOI) and occupancy growth in properties.
Latest Trefis Analyses
| Title | |
|---|---|
| ARTICLES |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 60.22 |
| Mkt Cap | 9.3 |
| Rev LTM | 1,361 |
| Op Inc LTM | 451 |
| FCF LTM | 551 |
| FCF 3Y Avg | 458 |
| CFO LTM | 670 |
| CFO 3Y Avg | 607 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 10.9% |
| Rev Chg 3Y Avg | 9.7% |
| Rev Chg Q | 10.6% |
| QoQ Delta Rev Chg LTM | 2.6% |
| Op Mgn LTM | 15.5% |
| Op Mgn 3Y Avg | 13.6% |
| QoQ Delta Op Mgn LTM | 0.2% |
| CFO/Rev LTM | 33.8% |
| CFO/Rev 3Y Avg | 32.8% |
| FCF/Rev LTM | 22.8% |
| FCF/Rev 3Y Avg | 22.0% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 9.3 |
| P/S | 8.5 |
| P/EBIT | 17.6 |
| P/E | 24.8 |
| P/CFO | 19.8 |
| Total Yield | 1.9% |
| Dividend Yield | 3.3% |
| FCF Yield 3Y Avg | 5.0% |
| D/E | 0.4 |
| Net D/E | 0.3 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 0.2% |
| 3M Rtn | 4.1% |
| 6M Rtn | 12.8% |
| 12M Rtn | 28.1% |
| 3Y Rtn | 74.2% |
| 1M Excs Rtn | -1.4% |
| 3M Excs Rtn | 4.1% |
| 6M Excs Rtn | 2.7% |
| 12M Excs Rtn | 13.8% |
| 3Y Excs Rtn | 7.7% |
Price Behavior
| Market Price | $5.84 | |
| Market Cap ($ Bil) | 1.4 | |
| First Trading Date | 02/23/2000 | |
| Distance from 52W High | -2.8% | |
| 50 Days | 200 Days | |
| DMA Price | $5.12 | $4.01 |
| DMA Trend | up | up |
| Distance from DMA | 14.2% | 45.6% |
| 3M | 1YR | |
| Volatility | 39.4% | 53.6% |
| Downside Capture | -113.94 | 16.07 |
| Upside Capture | 59.31 | 101.85 |
| Correlation (SPY) | 2.3% | 28.9% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 0.18 | -0.30 | 0.07 | 0.58 | 0.80 | 1.17 |
| Up Beta | 0.99 | 2.26 | 1.24 | 2.23 | 0.95 | 0.90 |
| Down Beta | 1.19 | 0.37 | 0.11 | 0.16 | 0.96 | 0.81 |
| Up Capture | 125% | -7% | 78% | 110% | 103% | 878% |
| Bmk +ve Days | 11 | 22 | 34 | 71 | 142 | 430 |
| Stock +ve Days | 11 | 21 | 31 | 64 | 129 | 360 |
| Down Capture | -349% | -281% | -134% | -74% | 18% | 106% |
| Bmk -ve Days | 9 | 19 | 27 | 54 | 109 | 321 |
| Stock -ve Days | 8 | 18 | 25 | 52 | 105 | 355 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with DHC | |
|---|---|---|---|---|
| DHC | 145.0% | 53.5% | 1.84 | - |
| Sector ETF (XLRE) | 1.0% | 16.3% | -0.12 | 33.2% |
| Equity (SPY) | 16.0% | 19.2% | 0.64 | 28.8% |
| Gold (GLD) | 66.9% | 23.7% | 2.11 | 13.4% |
| Commodities (DBC) | 7.0% | 16.3% | 0.23 | 23.5% |
| Real Estate (VNQ) | 2.9% | 16.5% | -0.00 | 37.2% |
| Bitcoin (BTCUSD) | -19.7% | 39.9% | -0.46 | 15.0% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with DHC | |
|---|---|---|---|---|
| DHC | 8.5% | 69.0% | 0.40 | - |
| Sector ETF (XLRE) | 5.0% | 19.0% | 0.17 | 40.1% |
| Equity (SPY) | 14.1% | 17.1% | 0.66 | 31.9% |
| Gold (GLD) | 19.9% | 16.6% | 0.97 | 9.7% |
| Commodities (DBC) | 11.4% | 18.9% | 0.49 | 8.4% |
| Real Estate (VNQ) | 4.5% | 18.8% | 0.15 | 43.7% |
| Bitcoin (BTCUSD) | 20.9% | 57.6% | 0.56 | 12.3% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with DHC | |
|---|---|---|---|---|
| DHC | -4.6% | 63.6% | 0.19 | - |
| Sector ETF (XLRE) | 6.8% | 20.5% | 0.29 | 49.6% |
| Equity (SPY) | 15.9% | 17.9% | 0.76 | 39.2% |
| Gold (GLD) | 15.0% | 15.3% | 0.81 | 6.6% |
| Commodities (DBC) | 8.3% | 17.6% | 0.39 | 16.1% |
| Real Estate (VNQ) | 5.8% | 20.8% | 0.25 | 54.7% |
| Bitcoin (BTCUSD) | 71.1% | 66.4% | 1.10 | 11.1% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/3/2025 | -4.9% | 1.8% | 8.1% |
| 8/4/2025 | 0.6% | -1.2% | 9.7% |
| 2/25/2025 | 8.6% | 7.3% | -0.8% |
| 11/4/2024 | -19.6% | -23.0% | -27.0% |
| 8/1/2024 | -1.2% | -5.5% | 5.8% |
| 5/6/2024 | -9.8% | -6.6% | 16.4% |
| 2/26/2024 | 7.0% | 3.0% | -21.7% |
| 11/1/2023 | 4.7% | -3.3% | 25.0% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 9 | 8 | 8 |
| # Negative | 11 | 12 | 12 |
| Median Positive | 7.0% | 6.5% | 20.7% |
| Median Negative | -4.7% | -5.6% | -14.8% |
| Max Positive | 59.1% | 103.2% | 49.5% |
| Max Negative | -19.6% | -23.0% | -46.4% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 09/30/2025 | 11/03/2025 | 10-Q |
| 06/30/2025 | 08/04/2025 | 10-Q |
| 03/31/2025 | 05/05/2025 | 10-Q |
| 12/31/2024 | 02/25/2025 | 10-K |
| 09/30/2024 | 11/04/2024 | 10-Q |
| 06/30/2024 | 08/01/2024 | 10-Q |
| 03/31/2024 | 05/06/2024 | 10-Q |
| 12/31/2023 | 02/26/2024 | 10-K |
| 09/30/2023 | 11/01/2023 | 10-Q |
| 06/30/2023 | 08/01/2023 | 10-Q |
| 03/31/2023 | 05/08/2023 | 10-Q |
| 12/31/2022 | 03/01/2023 | 10-K |
| 09/30/2022 | 11/02/2022 | 10-Q |
| 06/30/2022 | 08/03/2022 | 10-Q |
| 03/31/2022 | 05/03/2022 | 10-Q |
| 12/31/2021 | 02/24/2022 | 10-K |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Bilotto, Christopher J | President and CEO | Direct | Buy | 12162025 | 4.89 | 20,000 | 97,720 | 1,301,068 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.